Since December 2019, the world has been experiencing the challenge of facing coronavirus disease-19 (COVID-19), a severe infectious disease caused by the new coronavirus, SARS-CoV-2. The individuals with the mos
SYMPTOMSGLUCOSE-6-phosphate dehydrogenase deficiencyOLDER patientsCOVID-19On October 2020, Sestili and Fimognari reported that acetaminophen (N-aetyl-para-aminophenol), commonly known as paracetamol, induces or worsens glutathione (GSH) consumption in elderly patients affected by early or mild COVID-...
To best of our knowledge, the prevalence and risk of death of severe COVID-19 is higher in elderly patients with chronic comorbidities, such as arterial hypertension, type 2 diabetes, cardiac and cerebrovascular disorders, and COPD (Wang et al.2020b). Of note, diagnosis of major cardiac comp...
This scale exists of 15 Yes/No items and is designed to assess depressive symptoms in older populations. Using a score key, each item receives a score of 0 or 1 and these scores are then summed leading to a total score between 0 and 15, with higher scores indicating more depressive ...
and 90. The incidence of long-COVID symptoms was 41.6% (95% CI 37.8–45.4%). Females [aOR = 1.5 (95% CI 1.1–2.3)], the elderly [aOR = 4.9 (95% CI 2.0–11.3)], and those who required hospitalization [aOR = 5.0 (95% CI 1.3–3.7)] were at a higher risk of ...
Our findings are in contrast to the previous finding, suggesting that depressive symptoms are closely linked to higher likelihood of experiencing unmet healthcare needs [37]. This may imply that older adults with more sadness or depression may have no or limited healthcare needs because experience ...
Probable longer incubation period for elderly COVID-19 cases: analysis of 180 contact tracing data in Hubei Province, China. Risk Manag Healthc Policy. 2020;13:1111-1117. doi:10.2147/RMHP.S257907PubMedGoogle ScholarCrossref 25. de Laval F, Grosset-Janin A, Delon F, et al...
The mortality rate was approximately 1.76%, which is a reduction in patient mortality. Conclusions TCM combined with CWM improved clinical symptoms and reduced hospitalization and mortality rates.Introduction COVID-19 has remarkably weakened the global economy by threatening health systems worldwide. ...
In the post-COVID-19 pandemic period, individuals with HD may continue to visit emergency departments for long COVID-19 symptoms, such as fatigue, breathing difficulties, cognitive issues, muscle and joint pain, sleep disturbances, chest pain, heart palpitations, headaches, neuropsychiatric symptoms,...
Recent literature on the mental health consequences of social distancing measures has found a substantial increase in self-reported sleep disorders, anxiety and depressive symptoms during lockdown periods. We investigate this issue with data on monthly purchases of psychotropic drugs from the universe of...